Selected research
Industry Research
Danshen Injection Industry Research Report 2026
Market perspective
The global Danshen Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Danshen Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Danshen Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Danshen Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Danshen Injection include Changshu Leiyunshang Pharmaceutical, Fujian Gutian Pharmaceutical, Shineway Pharmaceutical, Langch Group, Green Valley Pharma, Sunnyhope Pharmaceutical, HuiKang Pharmaceutical and CHIATAI QINGCHUNBAO, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Danshen Injection market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Danshen Injection Market by Company
Changshu Leiyunshang Pharmaceutical
Fujian Gutian Pharmaceutical
Shineway Pharmaceutical
Langch Group
Green Valley Pharma
Sunnyhope Pharmaceutical
HuiKang Pharmaceutical
CHIATAI QINGCHUNBAO
Danshen Injection Segment by Type
2ml Per Tube
10ml Per Tube
Danshen Injection Segment by Application
Tertiary Hospital
Secondary Hospital
Others
Danshen Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Danshen Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Danshen Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Danshen Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Danshen Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Danshen Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Danshen Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 2ml Per Tube
- 10ml Per Tube
Applications
- Tertiary Hospital
- Secondary Hospital
- Others
Companies covered
- Changshu Leiyunshang Pharmaceutical
- Fujian Gutian Pharmaceutical
- Shineway Pharmaceutical
- Langch Group
- Green Valley Pharma
- Sunnyhope Pharmaceutical
- HuiKang Pharmaceutical
- CHIATAI QINGCHUNBAO
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Danshen Injection Market Size (2021-2032)
- 2.2.2 Global Danshen Injection Sales (2021-2032)
- 2.2.3 Global Danshen Injection Market Average Price (2021-2032)
- 2.3 Danshen Injection by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 2ml Per Tube
- 2.3.3 10ml Per Tube
- 2.4 Danshen Injection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Tertiary Hospital
- 2.4.3 Secondary Hospital
- 2.4.4 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Danshen Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Danshen Injection Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Danshen Injection Revenue of Manufacturers (2021-2026)
- 3.4 Global Danshen Injection Average Price by Manufacturers (2021-2026)
- 3.5 Global Danshen Injection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Danshen Injection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Danshen Injection, Product Type & Application
- 3.8 Global Manufacturers of Danshen Injection, Established Date
- 3.9 Global Danshen Injection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Changshu Leiyunshang Pharmaceutical
- 4.1.1 Changshu Leiyunshang Pharmaceutical Company Information
- 4.1.2 Changshu Leiyunshang Pharmaceutical Business Overview
- 4.1.3 Changshu Leiyunshang Pharmaceutical Danshen Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Changshu Leiyunshang Pharmaceutical Danshen Injection Product Portfolio
- 4.1.5 Changshu Leiyunshang Pharmaceutical Recent Developments
- 4.2 Fujian Gutian Pharmaceutical
- 4.2.1 Fujian Gutian Pharmaceutical Company Information
- 4.2.2 Fujian Gutian Pharmaceutical Business Overview
- 4.2.3 Fujian Gutian Pharmaceutical Danshen Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Fujian Gutian Pharmaceutical Danshen Injection Product Portfolio
- 4.2.5 Fujian Gutian Pharmaceutical Recent Developments
- 4.3 Shineway Pharmaceutical
- 4.3.1 Shineway Pharmaceutical Company Information
- 4.3.2 Shineway Pharmaceutical Business Overview
- 4.3.3 Shineway Pharmaceutical Danshen Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Shineway Pharmaceutical Danshen Injection Product Portfolio
- 4.3.5 Shineway Pharmaceutical Recent Developments
- 4.4 Langch Group
- 4.4.1 Langch Group Company Information
- 4.4.2 Langch Group Business Overview
- 4.4.3 Langch Group Danshen Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Langch Group Danshen Injection Product Portfolio
- 4.4.5 Langch Group Recent Developments
- 4.5 Green Valley Pharma
- 4.5.1 Green Valley Pharma Company Information
- 4.5.2 Green Valley Pharma Business Overview
- 4.5.3 Green Valley Pharma Danshen Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Green Valley Pharma Danshen Injection Product Portfolio
- 4.5.5 Green Valley Pharma Recent Developments
- 4.6 Sunnyhope Pharmaceutical
- 4.6.1 Sunnyhope Pharmaceutical Company Information
- 4.6.2 Sunnyhope Pharmaceutical Business Overview
- 4.6.3 Sunnyhope Pharmaceutical Danshen Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Sunnyhope Pharmaceutical Danshen Injection Product Portfolio
- 4.6.5 Sunnyhope Pharmaceutical Recent Developments
- 4.7 HuiKang Pharmaceutical
- 4.7.1 HuiKang Pharmaceutical Company Information
- 4.7.2 HuiKang Pharmaceutical Business Overview
- 4.7.3 HuiKang Pharmaceutical Danshen Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 HuiKang Pharmaceutical Danshen Injection Product Portfolio
- 4.7.5 HuiKang Pharmaceutical Recent Developments
- 4.8 CHIATAI QINGCHUNBAO
- 4.8.1 CHIATAI QINGCHUNBAO Company Information
- 4.8.2 CHIATAI QINGCHUNBAO Business Overview
- 4.8.3 CHIATAI QINGCHUNBAO Danshen Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 CHIATAI QINGCHUNBAO Danshen Injection Product Portfolio
- 4.8.5 CHIATAI QINGCHUNBAO Recent Developments
5 Global Danshen Injection Market Scenario by Region
- 5.1 Global Danshen Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Danshen Injection Sales by Region: 2021-2032
- 5.2.1 Global Danshen Injection Sales by Region: 2021-2026
- 5.2.2 Global Danshen Injection Sales by Region: 2027-2032
- 5.3 Global Danshen Injection Revenue by Region: 2021-2032
- 5.3.1 Global Danshen Injection Revenue by Region: 2021-2026
- 5.3.2 Global Danshen Injection Revenue by Region: 2027-2032
- 5.4 North America Danshen Injection Market Facts & Figures by Country
- 5.4.1 North America Danshen Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Danshen Injection Sales by Country (2021-2032)
- 5.4.3 North America Danshen Injection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Danshen Injection Market Facts & Figures by Country
- 5.5.1 Europe Danshen Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Danshen Injection Sales by Country (2021-2032)
- 5.5.3 Europe Danshen Injection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Danshen Injection Market Facts & Figures by Country
- 5.6.1 Asia Pacific Danshen Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Danshen Injection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Danshen Injection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Danshen Injection Market Facts & Figures by Country
- 5.7.1 South America Danshen Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Danshen Injection Sales by Country (2021-2032)
- 5.7.3 South America Danshen Injection Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Danshen Injection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Danshen Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Danshen Injection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Danshen Injection Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Danshen Injection Sales by Type (2021-2032)
- 6.1.1 Global Danshen Injection Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Danshen Injection Sales Market Share by Type (2021-2032)
- 6.2 Global Danshen Injection Revenue by Type (2021-2032)
- 6.2.1 Global Danshen Injection Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Danshen Injection Revenue Market Share by Type (2021-2032)
- 6.3 Global Danshen Injection Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Danshen Injection Sales by Application (2021-2032)
- 7.1.1 Global Danshen Injection Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Danshen Injection Sales Market Share by Application (2021-2032)
- 7.2 Global Danshen Injection Revenue by Application (2021-2032)
- 7.2.1 Global Danshen Injection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Danshen Injection Revenue Market Share by Application (2021-2032)
- 7.3 Global Danshen Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Danshen Injection Value Chain Analysis
- 8.1.1 Danshen Injection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Danshen Injection Production Mode & Process
- 8.2 Danshen Injection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Danshen Injection Distributors
- 8.2.3 Danshen Injection Customers
9 Global Danshen Injection Analyzing Market Dynamics
- 9.1 Danshen Injection Industry Trends
- 9.2 Danshen Injection Industry Drivers
- 9.3 Danshen Injection Industry Opportunities and Challenges
- 9.4 Danshen Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst